Status:
RECRUITING
Choices and Experiences Around Closed-loop Therapy in Type 1 Diabetes
Lead Sponsor:
University of Nottingham
Conditions:
Diabete Mellitus
Type 1 Diabetes Mellitus
Eligibility:
All Genders
18+ years
Brief Summary
Type 1 diabetes requires a lot of work to try to keep glucose levels in the target range. Hybrid closed- loop, also known as artificial pancreas, takes glucose readings from a sensor (continuous gluco...
Detailed Description
This is a cross-sectional online survey study, which involves people with type 1 diabetes who use closed-loop, wait to start closed-loop or considering closed-loop. The primary objective of the study...
Eligibility Criteria
Inclusion
- Age: ≥18 years (no upper age limit)
- Type 1 diabetes (any duration)
- People who use closed-loop therapy or wait to start closed-loop therapy or considering closed-loop therapy in the future
- Ability to give informed consent
Exclusion
- Any other type of diabetes apart from type 1 diabetes
Key Trial Info
Start Date :
September 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 1 2026
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT07177404
Start Date
September 1 2025
End Date
February 1 2026
Last Update
September 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospitals of Derby and Burton
Derby, United Kingdom